Sun Pharmaceutical Industries has entered into an agreement to acquire 100% outstanding shares of Innovcare Lifesciences. The deal is worth around Rs 271.2 crore. This strategic investment is aimed at strengthening the product portfolio of the company. The transaction is expected to be completed on or before July 31, 2026.
Innovcare Lifesciences is a company based in Mumbai and engaged in the business of marketing, distribution and sale of pharmaceutical drugs, nutraceutical and cosmeceutical products.
Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.
